{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:53:04Z","timestamp":1777517584606,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CIHR PS 168846"],"award-info":[{"award-number":["CIHR PS 168846"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s13318-023-00857-1","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T06:03:45Z","timestamp":1696917825000},"page":"709-722","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Effects of 16-HETE Enantiomers on Hypertrophic Markers in Human Fetal Ventricular Cardiomyocytes, RL-14 Cells"],"prefix":"10.1007","volume":"48","author":[{"given":"Rahmat","family":"Hidayat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud A.","family":"El-Ghiaty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif M.","family":"Shoieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed A.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8692-0400","authenticated-orcid":false,"given":"Ayman O. S.","family":"El-Kadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,10]]},"reference":[{"issue":"1","key":"857_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","volume":"128","author":"BC Bernardo","year":"2010","unstructured":"Bernardo BC, Weeks KL, Lynette PJRM. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther. 2010;128(1):191\u2013227.","journal-title":"Pharmacol Ther"},{"key":"857_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","volume":"65","author":"NOE Frey","year":"2003","unstructured":"Frey NOE. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol. 2003;65:45\u201379.","journal-title":"Annu Rev Physiol"},{"key":"857_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.21037\/amj.2020.03.03","volume":"5","author":"G Lippi","year":"2020","unstructured":"Lippi G, Sanchis-Gomar F. Global epidemiology and future trends of heart failure. AME Med J. 2020;5:15\u201315.","journal-title":"AME Med J"},{"key":"857_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","volume":"128","author":"BC Bernardo","year":"2010","unstructured":"Bernardo BC, Weeks KL, Pretorius LMJ. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther. 2010;128:191\u2013227.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"857_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.vascn.2014.11.005","volume":"7","author":"ZH Maayah","year":"2015","unstructured":"Maayah ZH, Elshenawy OH, Althurwi HN, Abdelhamid G, El-Kadi AOS. Human fetal ventricular cardiomyocyte, RL-14 cell line, is a promising model to study drug metabolizing enzymes and their associated arachidonic acid metabolites. J Pharmacol Toxicol Methods. 2015;7(1):33\u201341.","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"8","key":"857_CR6","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1124\/dmd.118.082073","volume":"46","author":"SM Shoieb","year":"2018","unstructured":"Shoieb SM, El-Kadi AOS. S-enantiomer of 19-hydroxyeicosatetraenoic acid preferentially protects against angiotensin II-induced cardiac hypertrophy. Drug Metab Dispos. 2018;46(8):1157\u201368.","journal-title":"Drug Metab Dispos"},{"key":"857_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/8786564","volume":"2016","author":"C Cabello-Verrugio","year":"2016","unstructured":"Cabello-Verrugio C, Ruiz-Ortega M, Mosqueira M, Simon F. Oxidative stress in disease and aging: mechanisms and therapies. Oxid Med Cell Longev. 2016;2016:1\u20132.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"857_CR8","first-page":"393","volume":"21","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang S, Huang Y, Yang K, Liu Y, Bi X, et al. Inhibition of CYP1B1 ameliorates cardiac hypertrophy induced by uremic toxin. Mol Med Rep. 2020;21(1):393\u2013404.","journal-title":"Mol Med Rep"},{"issue":"1","key":"857_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2045-8118-8-23","volume":"8","author":"A Jacob","year":"2011","unstructured":"Jacob A, Hartz AMS, Potin S, Coumoul X, Yousif S, Scherrmann JM, et al. Aryl hydrocarbon receptor-dependent upregulation of Cyp1b1 by TCDD and diesel exhaust particles in rat brain microvessels. Fluids Barriers CNS. 2011;8(1):1\u201312.","journal-title":"Fluids Barriers CNS"},{"issue":"35","key":"857_CR10","doi-asserted-by":"publisher","first-page":"12398","DOI":"10.1074\/jbc.AC120.014189","volume":"295","author":"MC Lafita-Navarro","year":"2020","unstructured":"Lafita-Navarro MC, Perez-Castro L, Zacharias LG, Barnes S, DeBerardinis RJ, Conacci-Sorrell M. The transcription factors aryl hydrocarbon receptor and MYC cooperate in the regulation of cellular metabolism. J Biol Chem. 2020;295(35):12398\u2013407.","journal-title":"J Biol Chem"},{"issue":"3","key":"857_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1615\/CritRevEukarGeneExpr.v18.i3.20","volume":"18","author":"TV Beischlag","year":"2008","unstructured":"Beischlag TV, Morales JL, Hollingshead BD, Perdew GH. The aryl hydrocarbon receptor complex and the control of gene expression. Crit Rev Eukaryot Gene Expr. 2008;18(3):207\u201350.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"1","key":"857_CR12","doi-asserted-by":"publisher","first-page":"18194","DOI":"10.1038\/s41598-021-97507-w","volume":"11","author":"R Haidar","year":"2018","unstructured":"Haidar R, Henkler F, Kugler J, Rosin A, Genkinger D, Laux P, et al. The role of DNA-binding and ARNT dimerization on the nucleo-cytoplasmic translocation of the aryl hydrocarbon receptor. Sci Rep. 2018;11(1):18194.","journal-title":"Sci Rep"},{"issue":"2","key":"857_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112360","volume":"397","author":"Y Gui","year":"2020","unstructured":"Gui Y, Chen J, Hu J, Liao C, Ouyang M, Deng L, et al. Soluble epoxide hydrolase inhibitors improve angiogenic function of endothelial progenitor cells via ERK\/p38-mediated miR-126 upregulation in myocardial infarction mice after exercise. Exp Cell Res. 2020;397(2): 112360.","journal-title":"Exp Cell Res"},{"issue":"3","key":"857_CR14","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/FJC.0b013e318273b007","volume":"61","author":"J Bellien","year":"2013","unstructured":"Bellien J, Joannides R. Epoxyeicosatrienoic acid pathway in human health and diseases. J Cardiovasc Pharmacol. 2013;61(3):188\u201396.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"14","key":"857_CR15","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1089\/scd.2016.0072","volume":"25","author":"M Waldman","year":"2016","unstructured":"Waldman M, Bellner L, Vanella L, Schragenheim J, Sodhi K, Singh SP, et al. Epoxyeicosatrienoic acids regulate adipocyte differentiation of mouse 3T3 cells, via PGC-1\u03b1 activation, which is required for HO-1 expression and increased mitochondrial function. Stem Cells Dev. 2016;25(14):1084\u201394.","journal-title":"Stem Cells Dev"},{"issue":"8","key":"857_CR16","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3109\/00498254.2012.754113","volume":"43","author":"A Anwar-Mohamed","year":"2013","unstructured":"Anwar-Mohamed A, El-Sherbeni A, Kim SH, Elshenawy OH, Althurwi HN, Zordoky BNM, et al. Acute arsenic treatment alters cytochrome P450 expression and arachidonic acid metabolism in lung, liver and kidney of C57Bl\/6 mice. Xenobiotica. 2013;43(8):719\u201329.","journal-title":"Xenobiotica"},{"issue":"4","key":"857_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/01.RES.0000012569.55432.02","volume":"90","author":"H Mollnau","year":"2002","unstructured":"Mollnau H, Wendt M, Sz\u00f6cs K, Lass\u00e8gue B, Schulz E, Oelze M, et al. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide\/cGMP signaling. Circ Res. 2002;90(4):1\u201310.","journal-title":"Circ Res"},{"issue":"6","key":"857_CR18","doi-asserted-by":"publisher","first-page":"706","DOI":"10.2174\/1389200211314060007","volume":"14","author":"OH Elshenawy","year":"2013","unstructured":"Elshenawy OH, Anwar-Mohamed A, El-Kadi AOS. 20-Hydroxyeicosatetraenoic acid is a potential therapeutic target in cardiovascular diseases. Curr Drug Metab. 2013;14(6):706\u201319.","journal-title":"Curr Drug Metab"},{"issue":"5","key":"857_CR19","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.phrs.2009.12.015","volume":"61","author":"A Anwar-mohamed","year":"2010","unstructured":"Anwar-mohamed A, Zordoky BNM, Aboutabl ME, El-Kadi AOS. Alteration of cardiac cytochrome P450-mediated arachidonic acid metabolism in response to lipopolysaccharide-induced acute systemic inflammation. Pharmacol Res. 2010;61(5):410\u20138.","journal-title":"Pharmacol Res"},{"issue":"1\u20132","key":"857_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11010-017-2943-y","volume":"429","author":"ZH Maayah","year":"2017","unstructured":"Maayah ZH, Althurwi HN, El-Sherbeni AA, Abdelhamid G, Siraki AG, El-Kadi AOS. The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol. Mol Cell Biochem. 2017;429(1\u20132):151\u201365.","journal-title":"Mol Cell Biochem"},{"key":"857_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1006\/abio.1993.1239","volume":"211","author":"SW Kennedy","year":"1993","unstructured":"Kennedy SW, Lorenzen A, James CA, Collins BT. Ethoxyresorufin-O-deethylase and porphyrin analysis in chicken embryo hepatocyte cultures with a fluorescence multiwell plate reader. Anal Biochem. 1993;211:102\u201312.","journal-title":"Anal Biochem"},{"issue":"173","key":"857_CR22","first-page":"7","volume":"1","author":"JHMH Waterborg","year":"1984","unstructured":"Waterborg JHMH. Method for quantitation. Protein Protoc Handb. 1984;1(173):7\u20139.","journal-title":"Protein Protoc Handb."},{"key":"857_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep15639","volume":"5","author":"HH Mosli","year":"2015","unstructured":"Mosli HH, Esmat A, Atawia RT, Shoieb SM, Mosli HA, Abdel-Naim A. Metformin attenuates testosterone-induced prostatic hyperplasia in rats: a pharmacological perspective. Sci Rep. 2015;5:1\u201310.","journal-title":"Sci Rep"},{"issue":"19","key":"857_CR24","doi-asserted-by":"publisher","first-page":"11903","DOI":"10.1021\/acs.est.5b02906","volume":"49","author":"JC Brennan","year":"2015","unstructured":"Brennan JC, He G, Tsutsumi T, Zhao J, Wirth E, Fulton MH, et al. Development of species-specific Ah receptor-responsive third generation CALUX cell lines with enhanced responsiveness and improved detection limits. Environ Sci Technol. 2015;49(19):11903\u201312.","journal-title":"Environ Sci Technol"},{"issue":"1","key":"857_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s42247-020-00136-8","volume":"4","author":"SM Shoieb","year":"2021","unstructured":"Shoieb SM, El-Ghiaty MA, El-Kadi AOS. Targeting arachidonic acid\u2013related metabolites in COVID-19 patients: potential use of drug-loaded nanoparticles. Emergent Mater. 2021;4(1):265\u201377.","journal-title":"Emergent Mater."},{"issue":"8","key":"857_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/bdd.517","volume":"27","author":"D Brocks","year":"2006","unstructured":"Brocks D. Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics. Biopharm Drug Dispos. 2006;27(8):387\u2013406.","journal-title":"Biopharm Drug Dispos"},{"issue":"1","key":"857_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.taap.2009.09.012","volume":"242","author":"BNM Zordoky","year":"2010","unstructured":"Zordoky BNM, Anwar-Mohamed A, Aboutabl ME, AOSE-K. Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats. Toxicol Appl Pharmacol. 2010;242(1):38\u201346.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"8","key":"857_CR28","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1124\/dmd.118.082073","volume":"46","author":"M Sherif","year":"2018","unstructured":"Sherif M, El-Kadi AO. S-enantiomer of 19-hydroxyeicosatetraenoic acid preferentially protects against angiotensin II-induced cardiac hypertrophy. Drug Metab Dispos. 2018;46(8):1157\u201368.","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"857_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1161\/HYPERTENSIONAHA.118.10269","volume":"72","author":"RJ Roman","year":"2018","unstructured":"Roman RJ, Fan F. 20-HETE: hypertension and beyond. Hypertension. 2018;72(1):12\u20138.","journal-title":"Hypertension"},{"issue":"1","key":"857_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/FJC.0000000000000494","volume":"70","author":"S Elkhatali","year":"2017","unstructured":"Elkhatali S, Maayah ZH, El-Sherbeni AA, Elshenawy OH, Abdelhamid G, Shoieb SM, et al. Inhibition of mid-chain HETEs protects against angiotensin II-induced cardiac hypertrophy. J Cardiovasc Pharmacol. 2017;70(1):16\u201324.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"857_CR31","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00204-014-1419-z","volume":"90","author":"ZH Maayah","year":"2016","unstructured":"Maayah ZH, El-Kadi AOS. 5-, 12- and 15-Hydroxyeicosatetraenoic acids induce cellular hypertrophy in the human ventricular cardiomyocyte, RL-14 cell line, through MAPK- and NF-\u03baB-dependent mechanism. Arch Toxicol. 2016;90(2):359\u201373.","journal-title":"Arch Toxicol"},{"issue":"5","key":"857_CR32","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","volume":"31","author":"E Ricciotti","year":"2011","unstructured":"Ricciotti E, A G F. [Eicosanoid neuroinflammation]. Prostaglandins and Inflammation. Arter Thromb Vasc Biol. 2011;31(5):986\u20131000.","journal-title":"Arter Thromb Vasc Biol"},{"key":"857_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jare.2017.11.004","volume":"11","author":"HERR Tallima","year":"2018","unstructured":"Tallima HERR. Arachidonic acid: physiological roles and potential health benefits\u2014a review. J Adv Res. 2018;11:33\u201341.","journal-title":"J Adv Res"},{"issue":"6I","key":"857_CR34","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1083\/jcb.111.6.2427","volume":"111","author":"GE Lyons","year":"1990","unstructured":"Lyons GE, Schiaffino S, Sassoon D, Barton P, Buckingham M. Developmental regulation of myosin gene expression in mouse cardiac muscle. J Cell Biol. 1990;111(6I):2427\u201336.","journal-title":"J Cell Biol"},{"key":"857_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/3467805","volume":"2017","author":"HF Wu","year":"2017","unstructured":"Wu HF, Chen YJ, Wu SZ, Lee CW, Chen IT, Lee YC, et al. Soluble epoxide hydrolase inhibitor and 14,15-epoxyeicosatrienoic acid-facilitated long-term potentiation through cAMP and CaMKII in the hippocampus. Neural Plast. 2017;2017:1\u201314.","journal-title":"Neural Plast"},{"issue":"19","key":"857_CR36","doi-asserted-by":"publisher","first-page":"17466","DOI":"10.1074\/jbc.M210804200","volume":"278","author":"M Krenz","year":"2003","unstructured":"Krenz M, Sanbe A, Bouyer-Dalloz F, Gulick J, Klevitsky R, Hewett TE, et al. Analysis of myosin heavy chain functionality in the heart. J Biol Chem. 2003;278(19):17466\u201374.","journal-title":"J Biol Chem"},{"issue":"4 49-4","key":"857_CR37","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1152\/ajpheart.2001.280.4.H1814","volume":"280","author":"PJ Reiser","year":"2001","unstructured":"Reiser PJ, Portman MA, Ning XH, Moravec CS. Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles. Am J Physiol Hear Circ Physiol. 2001;280(4 49-4):1814\u201320.","journal-title":"Am J Physiol Hear Circ Physiol."},{"issue":"4","key":"857_CR38","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/cvr\/cvs013","volume":"93","author":"PA Da Costa Martins","year":"2012","unstructured":"Da Costa Martins PA, De Windt LJ. MicroRNAs in control of cardiac hypertrophy. Cardiovasc Res. 2012;93(4):563\u201372.","journal-title":"Cardiovasc Res"},{"key":"857_CR39","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.cardiores.2005.10.001","volume":"69","author":"T Nishikimi","year":"2006","unstructured":"Nishikimi T, Maeda NMH. The role of natriuretic peptides in cardioprotection. Cardiovasc Res. 2006;69:318\u201328.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"857_CR40","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1136\/hrt.2005.071233","volume":"92","author":"M Weber","year":"2006","unstructured":"Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-PROBNP in clinical routine. Heart. 2006;92(6):843\u20139.","journal-title":"Heart"},{"issue":"21","key":"857_CR41","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1042\/CS20200310","volume":"134","author":"AN Carrera","year":"2020","unstructured":"Carrera AN, Grant MKOZB. CYP1B1 as a therapeutic target in cardio-oncology. Clin Sci. 2020;134(21):2897\u2013927.","journal-title":"Clin Sci"},{"issue":"1","key":"857_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/toxsci\/kfi282","volume":"88","author":"HM Korashy","year":"2005","unstructured":"Korashy HM, El-Kadi AOS. Regulatory mechanisms modulating the expression of cytochrome P450 1A1 gene by heavy metals. Toxicol Sci. 2005;88(1):39\u201351.","journal-title":"Toxicol Sci"},{"issue":"4","key":"857_CR43","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1124\/mol.110.064899","volume":"78","author":"SR Beedanagari","year":"2010","unstructured":"Beedanagari SR, Taylor RT, Bui P, Wang F, Nickerson DW, Hankinson O. Role of epigenetic mechanisms in differential regulation of the dioxin-inducible human CYP1A1 and CYP1B1 genes. Mol Pharmacol. 2010;78(4):608\u201316.","journal-title":"Mol Pharmacol"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-023-00857-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13318-023-00857-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-023-00857-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T18:29:32Z","timestamp":1699036172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13318-023-00857-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,10]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["857"],"URL":"https:\/\/doi.org\/10.1007\/s13318-023-00857-1","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,10]]},"assertion":[{"value":"14 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This work was supported by a grant from the Canadian Institutes of Health Research [CIHR PS 168846] to A.O.S.E.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"R.H, S.M.S, A.O.S.E: designed project and supervised the experiments. R.H.: conducted the experiments and performed data analysis. R.H. M.A.E., M.A.A. A.O.S.E: drafted the paper, interpreted the data, and prepared the manuscript for review. All authors have read and approved the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors contribution"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code of Availability"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}}]}}